In vitro chondrogenesis of Wharton's jelly mesenchymal stem cells in hyaluronic acid-based hydrogels
- PMID: 28536614
- PMCID: PMC5415830
- DOI: 10.1186/s11658-016-0016-y
In vitro chondrogenesis of Wharton's jelly mesenchymal stem cells in hyaluronic acid-based hydrogels
Abstract
Background: In this study, we evaluated the usefulness of two commercially available hyaluronic acid-based hydrogels, HyStem and HyStem-C, for the cultivation of Wharton's jelly mesenchymal stem cells (WJ-MSCs) and their differentiation towards chondrocytes.
Methods: The WJ-MSCs were isolated from umbilical cord Wharton's jelly using the explant method and their immunophenotype was evaluated via flow cytometry analysis. According to the criteria established by the International Society for Cellular Therapy, they were true MSCs. We assessed the ability of the WJ-MSCs and chondrocytes to grow in three-dimensional hydrogels and their metabolic activity. Chondrogenesis of WJ-MSCs in the hydrogels was determined using alcian blue and safranin O staining and real-time PCR evaluation of gene expression in the extracellular matrixes: collagen type I, II, III and aggrecan.
Results: Chondrocytes and WJ-MSCs cultured in the HyStem and HyStem-C hydrogels adopted spherical shapes, which are characteristic for encapsulated cells. The average viability of the WJ-MSCs and chondrocytes in the HyStem hydrogels was approximately 67 % when compared with the viability in 2D culture. Alcian blue and safranin O staining revealed intensive production of proteoglycans by the cells in the HyStem hydrogels. Increased expression of collagen type II and aggrecan in the WJ-MSCs cultured in the HyStem hydrogel in the presence of chondrogenic medium showed that under these conditions, the cells have a high capacity to differentiate towards chondrocytes. The relatively high viability of WJ-MSCs and chondrocytes in both HyStem hydrogels suggests the possibility of their use for chondrogenesis.
Conlusions: The results indicate that WJ-MSCs have some degree of chondrogenic potential in HyStem and HyStem-C hydrogels, showing promise for the engineering of damaged articular cartilage.
Keywords: Chondrocytes; Chondrogenesis; HyStem; HyStem-C; Hydrogels; WJ-MSCs.
Figures






Similar articles
-
Changes in expression of cartilaginous genes during chondrogenesis of Wharton's jelly mesenchymal stem cells on three-dimensional biodegradable poly(L-lactide-co-glycolide) scaffolds.Cell Mol Biol Lett. 2016 Aug 24;21:14. doi: 10.1186/s11658-016-0012-2. eCollection 2016. Cell Mol Biol Lett. 2016. PMID: 28536617 Free PMC article.
-
Chondrogenic induction of mesenchymal stromal/stem cells from Wharton's jelly embedded in alginate hydrogel and without added growth factor: an alternative stem cell source for cartilage tissue engineering.Stem Cell Res Ther. 2015 Dec 30;6:260. doi: 10.1186/s13287-015-0263-2. Stem Cell Res Ther. 2015. PMID: 26718750 Free PMC article.
-
Effect of nicotine on the proliferation and chondrogenic differentiation of the human Wharton's jelly mesenchymal stem cells.Biomed Mater Eng. 2017;28(s1):S217-S228. doi: 10.3233/BME-171644. Biomed Mater Eng. 2017. PMID: 28372298
-
Wharton's Jelly Mesenchymal Stem Cells: Shaping the Future of Osteoarthritis Therapy with Advancements in Chitosan-Hyaluronic Acid Scaffolds.Stem Cells Dev. 2025 Jan;34(1-2):1-16. doi: 10.1089/scd.2024.0033. Epub 2024 Nov 28. Stem Cells Dev. 2025. PMID: 39605205 Review.
-
Characteristics and clinical applications of Wharton's jelly-derived mesenchymal stromal cells.Curr Res Transl Med. 2020 Jan;68(1):5-16. doi: 10.1016/j.retram.2019.09.001. Epub 2019 Sep 19. Curr Res Transl Med. 2020. PMID: 31543433 Review.
Cited by
-
Steady Augmentation of Anti-Osteoarthritic Actions of Rapamycin by Liposome-Encapsulation in Collaboration with Low-Intensity Pulsed Ultrasound.Int J Nanomedicine. 2020 May 28;15:3771-3790. doi: 10.2147/IJN.S252223. eCollection 2020. Int J Nanomedicine. 2020. PMID: 32547027 Free PMC article.
-
Synovial fluid niche promoted differentiation of dental follicle mesenchymal stem cells toward chondrogenesis in rheumatoid arthritis.Arch Rheumatol. 2021 Nov 19;37(1):94-109. doi: 10.46497/ArchRheumatol.2022.8891. eCollection 2022 Mar. Arch Rheumatol. 2021. PMID: 35949879 Free PMC article.
-
Umbilical Cord Mesenchymal Stromal Cells for Cartilage Regeneration Applications.Stem Cells Int. 2022 Jan 6;2022:2454168. doi: 10.1155/2022/2454168. eCollection 2022. Stem Cells Int. 2022. PMID: 35035489 Free PMC article. Review.
-
Progress in the treatment of osteoarthritis with umbilical cord stem cells.Hum Cell. 2020 Jul;33(3):470-475. doi: 10.1007/s13577-020-00377-z. Epub 2020 May 23. Hum Cell. 2020. PMID: 32447573 Free PMC article. Review.
-
Injectable Peptide Hydrogel Encapsulation of Mesenchymal Stem Cells Improved Viability, Stemness, Anti-Inflammatory Effects, and Early Stage Wound Healing.Biomolecules. 2022 Sep 17;12(9):1317. doi: 10.3390/biom12091317. Biomolecules. 2022. PMID: 36139156 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources